Skip to main content

Paul Quinlan

Equibles does not estimate personal net worth.

Get an email with a short summary when Oruka Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ORKA alerts

About Paul Quinlan

Paul Quinlan is recorded as General Counsel at Oruka Therapeutics, Inc. (ORKA). The newest filing on record that lists Paul Quinlan as General Counsel at Oruka Therapeutics, Inc. (ORKA) is dated April 17, 2026. Oruka Therapeutics, Inc. reported in an 8-K filed September 5, 2024 that Paul Quinlan was appointed General Counsel and Secretary, effective August 29, 2024. The proxy statement of Oruka Therapeutics, Inc. reports total compensation of $2,338,593 for Paul Quinlan in fiscal 2025, including a base salary of $474,000. Disclosed compensation is on record for 2 fiscal years. Oruka Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Oruka Therapeutics, Inc. includes Lawrence Klein (CEO and Board Member), Thomas A. Keuer (CEO), Samarth Kulkarni (Chairman and Board Member) and 7 others.

“On August 29, 2024, the Board appointed Lawrence Klein as the Company’s President and Chief Executive Officer, Arjun Agarwal as the Company’s Senior Vice President, Finance and Treasurer, Joana Goncalves as the Company’s Chief Medical Officer and Paul Quinlan as General Counsel and Secretary, each to serve at the discretion of the Board.”
Oruka Therapeutics, Inc. Form 8-K, filed September 5, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Oruka Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Oruka Therapeutics, Inc. (ORKA) $474,000 $2,338,593
2024 Oruka Therapeutics, Inc. (ORKA) $155,854 $310,445

Recent activity